Potential for Gut Peptide-Based Therapy in Postprandial Hypotension

被引:16
|
作者
Borg, Malcolm J. [1 ,2 ]
Xie, Cong [1 ,2 ]
Rayner, Christopher K. [1 ,2 ]
Horowitz, Michael [1 ,2 ,3 ]
Jones, Karen L. [1 ,2 ,3 ]
Wu, Tongzhi [1 ,2 ,3 ]
机构
[1] Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Ctr Res Excellence Translating Nutr Sci Good Hlth, Adelaide, SA 5000, Australia
[3] Royal Adelaide Hosp, Endocrine & Metab Unit, Adelaide, SA 5000, Australia
基金
英国医学研究理事会;
关键词
postprandial hypotension; glucagon-like peptide-1; glucose-dependent insulinotropic polypeptide; somatostatin; diabetes mellitus; autonomic failure; GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; INTRADUODENAL GLUCOSE-INFUSION; ANALOG OCTREOTIDE SMS-201-995; SPLANCHNIC BLOOD-FLOW; HEART-RATE RESPONSES; ORAL GLUCOSE; ORTHOSTATIC HYPOTENSION; INCRETIN HORMONE; GLYCEMIC RESPONSES;
D O I
10.3390/nu13082826
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Postprandial hypotension (PPH) is an important and under-recognised disorder resulting from inadequate compensatory cardiovascular responses to meal-induced splanchnic blood pooling. Current approaches to management are suboptimal. Recent studies have established that the cardiovascular response to a meal is modulated profoundly by gastrointestinal factors, including the type and caloric content of ingested meals, rate of gastric emptying, and small intestinal transit and absorption of nutrients. The small intestine represents the major site of nutrient-gut interactions and associated neurohormonal responses, including secretion of glucagon-like peptide-1, glucose-dependent insulinotropic peptide and somatostatin, which exert pleotropic actions relevant to the postprandial haemodynamic profile. This review summarises knowledge relating to the role of these gut peptides in the cardiovascular response to a meal and their potential application to the management of PPH.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Peptide-Based Therapeutics in Cancer Therapy
    Jalil, Abduladheem Turki
    Abdulhadi, Mohanad Ali
    Al-Ameer, Lubna R.
    Taher, Waam Mohammed
    Abdulameer, Sada Jasim
    Abosaooda, Munther
    Fadhil, Ali A.
    MOLECULAR BIOTECHNOLOGY, 2024, 66 (10) : 2679 - 2696
  • [2] Peptide-based therapy in portal hypertension
    Mohanty, Arpan
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2020, 27 (01) : 22 - 27
  • [3] Peptide-Based Nanocarriers for Cancer Therapy
    Wei, Guoqing
    Wang, Yi
    Huang, Xuehui
    Hou, Huabo
    Zhou, Shaobing
    SMALL METHODS, 2018, 2 (09):
  • [4] Peptide-based vaccines for cancer therapy
    Parmiani, Giorgio
    Russo, Vincenzo
    Maccalli, Cristina
    Parolini, Danilo
    Rizzo, Nathalie
    Maio, Michele
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (11) : 3175 - 3178
  • [5] Peptide-based nanomaterials for gene therapy
    Zhang, Wei
    Chen, Qing
    Wu, Feng
    Dai, Jun
    Ding, Defang
    Wu, Jun
    Lou, Xiaoding
    Xia, Fan
    NANOSCALE ADVANCES, 2021, 3 (02): : 302 - 310
  • [6] Peptide-based vaccines for cancer: realizing their potential
    Kanodia, Shreya
    Kast, W. Martin
    EXPERT REVIEW OF VACCINES, 2008, 7 (10) : 1533 - 1545
  • [7] Potential of Peptide-Based Enhancers for Transdermal Delivery
    Lopes, Luciana B.
    Carvalho, Vanessa F. M.
    de Lemos, Debora P.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (20) : 2814 - 2822
  • [8] Versatile Peptide-Based Nanosystems for Photodynamic Therapy
    Li, Qiuyan
    Ming, Ruiqi
    Huang, Lili
    Zhang, Ruoyu
    PHARMACEUTICS, 2024, 16 (02)
  • [9] Functional peptide-based nanoparticles for photodynamic therapy
    Han, Kai
    Ma, Zhaoyu
    Han, Heyou
    JOURNAL OF MATERIALS CHEMISTRY B, 2018, 6 (01) : 25 - 38
  • [10] Recent advances in antimicrobial peptide-based therapy
    Mulukutla, Aditya
    Shreshtha, Romi
    Deb, Vishal Kumar
    Chatterjee, Pallabi
    Jain, Utkarsh
    Chauhan, Nidhi
    BIOORGANIC CHEMISTRY, 2024, 145